Cargando…

Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature

Klinefelter syndrome (KS) is a sex aneuploidy abnormality comprised by one additional X chromosome. It occurs in 1:500–1000 male births. As with women, an increased susceptibility to autoimmune diseases is present. We report three cases of coexisting EoE and KS for a prevalence of 2% in our EoE clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghisa, Matteo, Savarino, Vincenzo, Buda, Andrea, Katzka, David A., Savarino, Edoardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855470/ https://www.ncbi.nlm.nih.gov/pubmed/35186122 http://dx.doi.org/10.1177/17562848221076888

Ejemplares similares

Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients
por: Facchin, Sonia, et al.
Publicado: (2021)

Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak
por: Savarino, Edoardo, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis and GERD: links and risks
por: Ghisa, Matteo, et al.
Publicado: (2019)

Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak
por: Savarino, Edoardo Vincenzo, et al.
Publicado: (2020)

Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
por: Visaggi, Pierfrancesco, et al.
Publicado: (2023)

Prevention Strategies for Esophageal Cancer—An Expert Review
por: Marabotto, Elisa, et al.
Publicado: (2021)

Boerhaave’s syndrome as an initial presentation of eosinophilic esophagitis: a case series
por: Jackson, Whitney E., et al.
Publicado: (2013)

Gynecomastia and Klinefelter Syndrome
por: Singer-Granick, Carol J., et al.
Publicado: (2015)

The Lyon Consensus: Does It Differ From the Previous Ones?
por: Ghisa, Matteo, et al.
Publicado: (2020)

Clopidogrel-Induced Eosinophilic Colitis
por: Djahandideh Sheijani, Shirin, et al.
Publicado: (2023)

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy
por: Bagnasco, Diego, et al.
Publicado: (2023)

Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations
por: Ghisa, Matteo, et al.
Publicado: (2020)

A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis
por: Massimino, Luca, et al.
Publicado: (2023)

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
por: Zingone, Fabiana, et al.
Publicado: (2020)

Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
por: Barberio, Brigida, et al.
Publicado: (2021)

Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020)

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
por: Marabotto, Elisa, et al.
Publicado: (2020)

Biliary Tree Diagnostics: Advances in Endoscopic Imaging and Tissue Sampling
por: Ghisa, Matteo, et al.
Publicado: (2022)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
por: Savarino, Vincenzo, et al.
Publicado: (2021)

Recent advances in understanding/managing eosinophilic esophagitis in adults
por: Katzka, David A.
Publicado: (2015)

Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre
por: Zingone, Fabiana, et al.
Publicado: (2020)

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
por: Menzella, Francesco, et al.
Publicado: (2021)

Quality-of-Life Evaluation in Coeliac Patients on a Gluten-Free Diet
por: Marsilio, Ilaria, et al.
Publicado: (2020)

Distinction between patients with non-erosive reflux disease and functional heartburn
por: Giacchino, Maria, et al.
Publicado: (2013)

Efficacy of teduglutide in a patient with Crohn’s disease and short bowel syndrome on enteral nutrition: let’s start to think out of the box
por: Barberio, Brigida, et al.
Publicado: (2019)

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
por: Barberio, Brigida, et al.
Publicado: (2022)

Progression from an Inflammatory to a Fibrostenotic Phenotype in Eosinophilic Esophagitis
por: Koutlas, Nathaniel T., et al.
Publicado: (2017)

Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients
por: Savarino, Edoardo, et al.
Publicado: (2015)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Relevance of Measuring Substances in Bronchoalveolar Lavage Fluid for Detecting Aspiration-associated Extraesophageal Reflux Disease
por: Savarino, Edoardo, et al.
Publicado: (2017)

High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy
por: Ribolsi, Mentore, et al.
Publicado: (2020)

Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics
por: Ribolsi, Mentore, et al.
Publicado: (2021)

Optimal management of constipation associated with irritable bowel syndrome
por: Furnari, Manuele, et al.
Publicado: (2015)

Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
por: Marasco, Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sula52h2i3i7crkgoe3dq3i4n6